Cancer breakthroughs trigger big pharma interest in drugs and deals

white-blood-cell-543471_1280.jpg (969×1280)

Companies are scrambling to get into the immunotherapy market, which experts think could eventually be worth up to £26bn a year in sales.

The new generation of drugs hailed as a once-in-a-generation advance in treatment for cancer patients is also viewed as good news for the pharmaceutical industry – just when analysts had started to voice concerns that the pipeline of blockbuster treatments in development was starting to run dry.

Immunotherapy treatments, which use the body’s immune system to attack cancerous cells, could be as revolutionary as the arrival of chemotherapy was in the 1940s – and big pharma companies have been scrambling to get into a market that experts think could eventually be worth up to £26bn a year in sales.

“It is a really significant breakthrough” said Colin White, lead analyst for oncology at the research group Datamonitor Healthcare. “It is being seen as the third major breakthrough in cancer treatments: the first being chemotherapy, the second being targeted treatments and the third being immunotherapy.”

Read more here:

http://www.theguardian.com/business/2015/jun/01/cancer-breakthroughs-trigger-big-pharma-interest-drugs-deals

 

Researchers find ‘lost’ memories using light

image0011

The finding answers a fiercely debated question in neuroscience as to the nature of amnesia, according to Susumu Tonegawa, the Picower Professor in MIT’s Department of Biology and director of the RIKEN-MIT Center at the Picower Institute for Learning and Memory, who directed the research by lead authors Tomas Ryan, Dheeraj Roy, and Michelle Pignatelli.

Read more here:

http://medicalxpress.com/news/2015-05-lost-memories.html

 

Researchers hail new cancer treatment. Unlocking the body’s immune system.

(CNN)—Researchers meeting in Chicago are hailing what they believe may be a potent new weapon in the fight against cancer: the body’s own immune system.

An international study found that a combination of two drugs that helped allow the immune system to fight the cancer — ipilimumab and nivolumab — stopped the deadly skin cancer melanoma from advancing for nearly a year in 58% of the cases.

Melanoma, though a skin cancer, can spread to the lungs, liver, bone, lymph nodes and brain.

Read and  watch more here.

http://edition.cnn.com/2015/06/01/health/immunotherapy-cancer-treatment-advance/index.html